There are 3397 resources available
Invited Discussant 1017O, 1018O and 1019O
Presenter: Inge-Marie Svane
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Challenging the status quo of early phase clinical trial design: Project Optimus
Resources:
Slides
Webcast
Discussion and Q&A
Presenter: All Speakers
Session: ESMO/ASCO Global Curriculum: Medical oncology Training: Challenges and opportunities
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: In collaboration with the IARC - Cancer prevention: What every oncologist must know
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Webcast
Conclusions and perspectives
Presenter: Mirat Shah
Session: Challenging the status quo of early phase clinical trial design: Project Optimus
Resources:
Webcast
242MO - Association of tumor-infiltrating lymphocytes (TILs) with recurrence score (RS) in patients with hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer (BC): A translational analysis of four prospective multicentric studies
Presenter: Federica Miglietta
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA24 - Multiparametric prognostic score in early HR+/HER2- breast cancer: Impact of recurrence score, clinical-pathological factors, gene mutations and histology
Presenter: Oleg Gluz
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Invited Discussant 240MO, LBA23, 241MO, 242MO and LBA24
Presenter: Carsten Denkert
Session: Mini oral session - Breast cancer, early stage
Resources:
Slides
Webcast
243MO - Omission of breast surgery after neoadjuvant systemic therapy for invasive cancer: Three-year preplanned primary-endpoint on a phase II multicentre prospective trial
Presenter: Henry M. Kuerer
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast